Skip to main content
v2026.11,610 entries · CC-BY 4.0

Flow Cytometry: Principles, Panel Design, and Gating Workflow

A complete guide to flow cytometry: fluidics/optics/electronics, FSC/SSC, panel design and staining index, compensation vs. spectral unmixing, FMO vs. isotype controls, a full gating sequence, sample-prep artifacts, sorting biosafety, MIFlowCyt/FlowRepository reporting, and core-facility recharge rates.

Ask about Flow Cytometry: Principles, Panel Design, and Gating Workflow

Answers are drawn from this guide and the rest of the CASRAI corpus, with a link to every source.

Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this

Written and maintained by CASRAI Editorial Board

Last updated

A dot plot with two population blobs and a polygon drawn around one of them is meaningless without knowing what happened to the cells before that plot: what was excluded as debris, what was excluded as a doublet, what was excluded as dead, and what the axes are actually measuring. Flow cytometry is a single-cell measurement technique — it passes cells one at a time through a laser and records how each one scatters light and fluoresces — and every plot downstream is a record of a filtering decision, not a raw picture of the sample. This guide walks through how the instrument physically works; how a fluorophore panel is actually designed and why that design step — not the instrument, not the analysis software — is what determines whether the resulting data can be trusted; the real distinction between conventional compensation and spectral unmixing; a standard gating sequence from raw events to the population you care about; sample-prep artifacts and the biosafety requirements for sorting infectious or unfixed material; and the reporting, data-deposition, and core-facility budgeting questions that a vendor manual doesn’t cover.

What Flow Cytometry Actually Measures

A flow cytometer suspends cells (or other particles — beads, nuclei, bacteria) in fluid and forces them, one at a time, through a narrow interrogation point where they cross one or more focused laser beams. As each cell crosses the beam, it scatters laser light in characteristic ways depending on its size and internal complexity, and any fluorescent molecules bound to or expressed by the cell — antibody-conjugated dyes, fluorescent proteins, viability dyes — are excited and emit light at a longer wavelength. Detectors positioned around the interrogation point convert that scattered and emitted light into electrical signals, and the instrument’s software records a full set of these measurements — one row of data — for every single cell that passes through, typically thousands to tens of thousands of cells per second. The output isn’t an image; it’s a table where every row is one cell and every column is one measured parameter (a scatter channel or a fluorescence channel), and the plots used to read the data are just different ways of visualizing that table.

The Three Systems: Fluidics, Optics, and Electronics

Fluidics: Hydrodynamic Focusing

The sample doesn’t simply drip past the laser — it has to be delivered one cell at a time, in single file, or the scatter and fluorescence readings from adjacent cells would blur together. Cytometers achieve this with hydrodynamic focusing: the cell suspension (the sample core) is injected into the center of a much faster-flowing stream of cell-free sheath fluid. Because the sheath fluid moves faster and surrounds the sample core symmetrically, it constricts the core stream down to a narrow thread only slightly wider than a single cell, lining cells up single file at the laser interrogation point. The ratio of sheath flow rate to sample flow rate controls both how tightly cells are focused (higher sheath flow narrows the core more, improving measurement precision) and how fast cells pass through the system (the acquisition rate).

Optics: Lasers and the Interrogation Point

At the interrogation point, one or more lasers of fixed wavelengths intersect the sample stream. Common laser lines on a standard configuration include violet (~405 nm), blue (~488 nm), yellow-green (~561 nm), and red (~633–640 nm); which lasers an instrument has determines which fluorophores it can excite well. As a cell crosses a laser beam, light is scattered in multiple directions and, if the cell carries fluorescent labels excitable by that laser’s wavelength, those fluorophores emit light of their own. A series of dichroic mirrors and bandpass optical filters splits this mixed light by wavelength and routes each slice to a dedicated detector, so that (for example) green emission around 519 nm and orange emission around 578 nm are measured on separate channels even though both fluorophores may have been excited by the same 488 nm laser.

Electronics: Detectors and Signal Digitization

Scattered and emitted light is weak, so cytometers use photomultiplier tubes (PMTs) — or, on newer instruments, avalanche photodiodes — to amplify the signal before it’s digitized. Each detector produces a voltage pulse as a cell crosses the laser; the instrument’s electronics characterize that pulse in a few standard ways — height (the peak voltage), area (the integrated signal under the pulse), and width (how long the pulse lasted) — and it’s the relationship between these pulse characteristics, not just their raw magnitude, that makes doublet discrimination possible (see the gating section below). The digitized values for every parameter, for every cell, are what get written to the list-mode data file (commonly an .fcs file) that gating software reads.

Forward Scatter and Side Scatter: What They Physically Report

Two scatter measurements are on essentially every flow experiment and form the backbone of the first gating step:

  • Forward scatter (FSC) is light scattered at a narrow angle roughly in line with the laser beam. It correlates primarily with cell size — larger cells scatter more light forward. It’s a rough, relative measure, not a calibrated size in microns, but it’s reliable enough to separate cells from smaller debris and to distinguish broad size classes (small lymphocytes from larger monocytes, for example).
  • Side scatter (SSC) is light scattered at roughly 90° to the laser beam. It correlates with internal complexity — granularity, membrane folding, nuclear-to-cytoplasm ratio, and organelle content. A granulocyte with dense cytoplasmic granules produces much higher SSC than a lymphocyte of similar size.

Plotted against each other, FSC and SSC produce the familiar first dot plot of a whole-blood or PBMC (peripheral blood mononuclear cell) sample, where lymphocytes, monocytes, and granulocytes separate into distinguishable clusters purely on the basis of size and granularity, before any fluorescent staining is even considered.

Fluorophores and Laser Lines

Choosing a fluorophore panel means matching each dye’s excitation peak to a laser line the instrument actually has, and its emission peak to a detector the instrument has fitted with the right filter — and making sure that dyes excited by the same laser don’t emit at wavelengths too close together to separate cleanly. The table below shows commonly used fluorophores and the laser line each is typically paired with; exact excitation/emission maxima vary slightly by manufacturer and dye formulation, so treat these as typical ranges rather than fixed values, and always confirm against your instrument’s configuration and the dye manufacturer’s spec sheet before designing a panel.

Fluorophore Typical laser line Typical emission peak Common use
FITC / Alexa Fluor 488 Blue (488 nm) ~519 nm (green) Surface marker antibody conjugate
PE (phycoerythrin) Blue (488 nm) or yellow-green (561 nm) ~578 nm (orange) Surface marker antibody conjugate
PerCP / PerCP-Cy5.5 Blue (488 nm) ~677–695 nm (red) Surface marker antibody conjugate
APC (allophycocyanin) Red (633–640 nm) ~660 nm (far red) Surface marker antibody conjugate
Pacific Blue / eFluor 450 Violet (405 nm) ~450 nm (blue) Surface marker antibody conjugate
DAPI Violet (405 nm) ~461 nm (blue) DNA content / dead-cell exclusion (compromised membranes only)
7-AAD Blue (488 nm) ~647 nm (red) Viability dye (excluded by intact membranes)
Propidium iodide Blue (488 nm) or yellow-green (561 nm) ~617 nm (orange-red) Viability dye / cell-cycle DNA content

Panel Design: Why This Step Actually Determines Data Quality

The single biggest determinant of whether a multicolor flow experiment produces clean, interpretable data is decided before a single cell is stained: which fluorophore gets assigned to which antigen. A poorly designed panel cannot be rescued afterward by better compensation, better gating, or a better instrument — resolution lost to a bad fluorophore/antigen pairing is baked into the raw signal.

Match Fluorophore Brightness to Antigen Density

Antibody targets vary widely in expression density, and fluorophores vary widely in brightness. The controlling rule: assign the brightest available fluorophores to the dimmest, most weakly expressed, or most biologically important antigens, and reserve dimmer fluorophores for antigens expressed at high density or used only for broad population definition (a viability dye or a broad lineage-exclusion marker, for example, tolerates a dim fluorophore well). A dim fluorophore on a low-density antigen produces a positive population that barely separates from background; the same antigen detected with a bright fluorophore separates cleanly — this one design decision does more to determine whether a panel resolves rare or dim populations than any instrument setting made afterward.

The metric used to rank fluorophore performance for this purpose is the staining index (SI): SI = (MFIpositive − MFInegative) / (2 × SDnegative), where MFI is the median (or mean) fluorescence intensity and SD is the standard deviation of the negative population. SI captures both how far apart the positive and negative populations sit and how tightly the negative population is distributed — a fluorophore with high raw signal but a wide, noisy negative population can have a worse SI, and worse real-world resolution, than a dimmer fluorophore with a tight negative peak. Vendor panel-design tools (BD, Beckman Coulter, Thermo Fisher spectrum viewers) publish relative brightness/SI rankings for their reagents on specific instrument configurations; treat these as a starting point for that vendor’s instrument and reagent lot, not a universal ranking that transfers unchanged to a different platform.

Spillover Spreading, Not Just Spillover

Compensation (see below) corrects the mean shift spillover causes, but it does not remove the added variance — the spread — that spillover introduces into the corrected channel. This is spillover spreading: the more channels a bright fluorophore spills into, and the more channels are compensated against it, the wider (noisier) each of those channels becomes after compensation, even though the mean is corrected. A spillover spreading matrix (SSM) quantifies this pairwise for every fluorophore combination in a panel and is the tool used to catch a bad pairing before running real samples: a very bright fluorophore assigned to a channel that spreads heavily into the channel used for a dim, rare population will degrade that population’s resolution even with perfect compensation. The practical consequence is the same design rule from a different angle — keep the brightest fluorophores on channels with the least biologically important spread, and never let a bright fluorophore’s spillover land in the channel carrying the rarest or dimmest target.

A Practical Panel-Building Order

  1. List every antigen the experiment needs, and rank them by expected expression density and biological priority — a rare or dim population that must be resolved outranks a bright, high-density lineage marker used only for broad gating.
  2. Rank the fluorophores available on the instrument’s configuration by staining index / relative brightness.
  3. Assign the brightest fluorophores to the lowest-density, highest-priority antigens first; assign the dimmest fluorophores to the highest-density, lowest-priority antigens.
  4. Check the resulting pairings against a spillover spreading matrix for the panel, and re-pair any combination where a bright fluorophore’s spread lands on a dim target’s channel.
  5. Titrate every antibody in the final panel — the manufacturer’s suggested concentration is a starting point, not a validated value for your cells, buffer, and instrument.

Adding fluorophores one at a time after the fact, without revisiting this ranking, is the most common way an otherwise reasonable panel ends up with a bright dye sitting on a low-priority marker while a critical rare population is stuck behind a dim one.

Compensation vs. Spectral Unmixing: Conventional and Spectral Cytometry

Fluorophores don’t emit at a single wavelength — each has an emission spectrum, a range of wavelengths with a peak somewhere in the middle, and those spectra overlap. FITC, for instance, emits some light in the wavelength range typically used to detect PE, even though its peak is elsewhere. That means the detector assigned to the “PE channel” picks up a real signal from FITC-positive cells even if they aren’t stained with any PE at all — a false-positive signal that isn’t a mistake in staining, it’s a mathematical consequence of how light and filters work.

Conventional Cytometry: Compensation

On a conventional instrument (one detector, behind one bandpass filter, assigned to each fluorophore), compensation is the mathematical correction applied after acquisition, or configured before it, that subtracts the calculated spillover of each fluorophore into every other fluorophore’s channel. It’s calculated from single-stain compensation controls — a sample stained with only one fluorophore at a time, run for every fluorophore in the panel — which measure exactly how much of that fluorophore’s signal lands in every other channel.

Spectral Cytometry: Unmixing

A spectral cytometer replaces the one-detector-per-fluorophore architecture with a bank of many detectors (often 30–64 or more) that each capture a narrow slice of the light generated at every laser, so every event is recorded as a full emission spectrum — a signature across every detector — rather than a single value per fluorophore channel. Because each dye’s complete spectral shape is captured, not just its peak-emission channel, spectral unmixing can mathematically distinguish fluorophores whose peak emission is nearly identical but whose overall spectral shape differs — separations conventional compensation, built around single peak channels, cannot reliably make. Unmixing uses reference spectra (single-stain controls collected on the same instrument, playing the same role single-stain compensation controls play conventionally) to solve for how much of each dye’s full spectrum is present in each cell’s measured spectrum, rather than subtracting a scalar spillover value from one channel. In practice this lets spectral platforms resolve more simultaneous fluorophores in a single panel than a comparably laser-equipped conventional instrument, at the cost of needing every reference control collected on that exact spectral configuration — a reference spectrum from a different instrument, or a different fluorophore lot, is not interchangeable.

The distinction matters operationally, not just technically: a conventional compensation matrix and a spectral unmixing matrix are not interchangeable, reference controls for one cannot substitute for the other, and panel-design/spillover-spreading tools built for one platform don’t transfer directly to the other. Confirm with the core facility which platform a given instrument actually is before reusing controls or a panel design across instruments. Under- or over-compensated (or poorly unmixed) data is one of the most common causes of a dot plot that looks wrong — populations that appear to smear diagonally, or a population that appears falsely double-positive — and it’s a data-processing artifact to rule out before concluding a biological result is real.

Controls: Unstained, FMO, and Isotype — What Each One Actually Tells You

These three controls are often confused with each other because all three involve “a tube that isn’t the full stain,” but they answer different questions and aren’t interchangeable:

  • Unstained control: cells with no antibody or dye added at all. It establishes the cells’ natural autofluorescence — the baseline signal every detector picks up from the cells themselves, before any stain is added. It’s the starting reference point for setting initial voltages, not a gating boundary for a specific marker.
  • Fluorescence-minus-one (FMO) control: the full staining panel, with every fluorophore included except one. It shows how much spillover from all the other dyes in the panel lands in that one channel, which is exactly the information needed to set an accurate positive/negative gate boundary for that specific marker in that specific panel. Because spillover depends on the whole panel, an FMO has to be run for every panel it’s used with — it isn’t reusable across different staining combinations.
  • Isotype control: an antibody of the same isotype, species, and conjugate as the specific antibody being tested, but with no relevant specificity for the target antigen. It’s meant to estimate background staining caused by non-specific antibody binding (such as Fc receptor binding) rather than spillover. Isotype controls have fallen out of favor for setting gates in modern multicolor panels precisely because they don’t account for spillover the way an FMO does — a well-titrated FMO control is now the standard for gate-setting in most panels, with isotype controls reserved for specifically questioning whether a signal reflects true antigen binding versus non-specific antibody binding.

Using an isotype control where an FMO is needed (or vice versa) is a common source of a gate that’s set in the wrong place — know which question you’re actually trying to answer before choosing the control.

Reading the Plots: Histograms, Dot Plots, and Contour Plots

  • Histogram: a single parameter on the x-axis (a fluorescence or scatter channel) against event count on the y-axis. Best for comparing the distribution of one marker across two or more samples or conditions overlaid on the same axes — for example, comparing a stained sample’s peak position and spread against an FMO control to see whether a population is genuinely shifted.
  • Dot plot (scatter plot): two parameters plotted against each other, with one dot per cell (or, on dense datasets, dots that increasingly overlap). Best for identifying distinct populations defined by two markers simultaneously — a CD4 vs. CD8 dot plot, for instance, or the FSC vs. SSC plot used for the first gating step.
  • Contour plot (or density plot): the same two-parameter comparison as a dot plot, but rendered as contour lines or a color density gradient instead of individual dots, so that overlapping populations in a dense dataset remain visually interpretable instead of collapsing into a solid mass of overlapping dots. Contour and density plots are generally easier to read than dot plots once event counts get into the tens of thousands.

All three are views of exactly the same underlying per-cell data table — switching from one plot type to another doesn’t change what was measured, only how it’s displayed.

The Standard Gating Sequence, Step by Step

“Gating” means drawing a boundary around a population of interest on a plot and restricting all downstream analysis to only the cells inside that boundary. A typical analysis works through gates in this order, each one narrowing the dataset before the next question is asked:

  1. Debris exclusion. On the initial FSC vs. SSC dot plot, a low-FSC, low-SSC cluster near the origin represents debris, dead cell fragments, and small particles rather than intact cells of interest. This population is excluded first with a gate drawn around the higher-FSC cluster of intact cells, before any other question is asked.
  2. Singlet discrimination (doublet exclusion). Two cells stuck together and passing through the laser as one event will register a similar peak height to a single larger cell but a longer pulse duration, since it takes longer for two stuck-together cells to cross the beam than one. Plotting FSC-Height against FSC-Area (or FSC-Area against FSC-Width, depending on the instrument) shows true single cells falling on a tight diagonal line, while doublets and clumps fall off that line with a disproportionately higher area or width relative to their height. A gate drawn around the diagonal singlet population removes doublets, which would otherwise appear as false double-positive events in later gates.
  3. Live/dead discrimination. Using a viability dye (7-AAD, propidium iodide, or a fixable amine-reactive viability dye, depending on whether the protocol includes fixation) gated on the singlet population, dead and dying cells — whose compromised membranes let viability dyes in, or whose amine-reactive dyes bind more total protein through a permeabilized membrane — are excluded. Dead cells bind antibodies non-specifically at a much higher rate than live cells, so skipping this gate is a common cause of spurious “positive” populations downstream.
  4. Population of interest. Only now, on the live, single, non-debris cells, are the actual experimental markers gated — for example, gating CD3+ T cells, then CD4 vs. CD8 within that T cell gate, then an activation or cytokine marker within the CD4 or CD8 subset. Each successive gate is drawn on the population defined by the gate before it, which is why gating strategies are usually diagrammed as a tree or hierarchy rather than a flat list of plots.

Getting the order right matters: gating on a marker of interest before excluding debris, doublets, and dead cells routinely inflates or distorts the apparent size and phenotype of the population being studied, because non-viable and non-singlet events haven’t been removed from the denominator yet.

Sample Preparation Artifacts to Rule Out Before Trusting a Result

  • Cell clumping and aggregation. Cells that stick together — common after enzymatic or mechanical dissociation of solid tissue, or after fixation without adequate resuspension — inflate the doublet/multiplet gate and can be mistaken for a distinct high-FSC population; filtering the sample through a cell strainer (commonly 35–40 μm mesh) immediately before acquisition is standard practice specifically to reduce this.
  • Over-digestion during tissue dissociation. Aggressive enzymatic or mechanical dissociation can strip surface epitopes — reducing antibody binding for the very markers being measured — or generate debris and stressed/dying cells that inflate the low-FSC/low-SSC and dead-cell gates. The dissociation protocol is part of the experiment, not a preliminary step separate from it.
  • Fixation changes scatter properties. Fixed cells routinely show altered FSC/SSC compared to the same cells live, which is why a gating strategy validated on live cells doesn’t automatically transfer to a fixed/permeabilized protocol without re-checking the scatter gates.
  • Tandem dye degradation. Tandem fluorophores (built from two conjugated fluorochromes, such as PE-Cy7 or APC-Cy7) can degrade with light exposure or storage time, shifting emission back toward the donor dye’s peak and increasing spillover into unexpected channels; if a panel that previously compensated cleanly suddenly does not, check the tandem reagents against a fresh lot before troubleshooting anything else.
  • Acquisition-rate and pressure artifacts. Running samples at too high an event rate increases the coincidence rate at the interrogation point, inflating apparent doublets; a partial clog mid-run changes flow pressure and can shift FSC/SSC values for the remainder of that file relative to its beginning — one reason a time-versus-parameter plot is a routine data-quality check before analysis, not an optional one.

Common Reading Mistakes

  • Treating FSC as a precise, calibrated size measurement. It’s a relative, instrument-specific value useful for comparison within a run, not a micron measurement without calibration beads.
  • Setting a positive/negative gate by eye against an unstained control instead of an FMO. Autofluorescence alone underestimates where spillover from other dyes in the panel will actually land.
  • Skipping doublet discrimination on a panel that includes DNA content or cell-cycle analysis, where doublets are especially likely to be misread as a distinct ploidy population.
  • Over-interpreting a small percentage difference between samples without checking equivalent event counts were collected in the relevant gate — a rare population’s percentage becomes statistically unstable at low event counts.

Cell Sorting vs. Analysis, and Biosafety When Sorting Infectious or Unfixed Material

Everything above describes flow cytometry as an analytical technique: cells are measured and the data is recorded, but the cells themselves are not physically separated. A cell sorter — fluorescence-activated cell sorting, FACS, originally a BD trademark now used generically — adds a physical separation step on top of the same optical measurement: the fluid stream is broken into individually charged droplets, and each droplet is deflected by an electrostatic field into a collection vessel based on which population it was measured to belong to, in real time. The measurement principles, controls, and gating logic above are identical for sorting; sorting adds droplet generation, charging, deflection, and collection on top of the same optical system. Those additions bring their own settings, and they are what decide whether a sort actually works: choosing the nozzle, sheath pressure and sort mode for a cell sort covers how nozzle diameter and pressure are selected from cell size, why the sort mode is a droplet-conflict rule rather than a quality dial, and how post-sort purity and viability are verified.

Sorting an unfixed sample containing an infectious agent, a primary human sample of unknown infectious status, or any biosafety-level-2-or-higher organism is a materially different biosafety problem than analyzing the same sample on a closed analyzer, because sorting generates aerosols at the point where the stream breaks into droplets and at any point of stream instability — often in open air on conventional sorter designs, not inside a sealed cuvette. Institutional biosafety guidance (the NIH/CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL)) and most institutional biosafety committees require, for BSL-2 or higher material on a sorter: an aerosol management system or biosafety-cabinet-style enclosure around the sort chamber, a documented instrument-specific risk assessment and IBC approval before sorting begins, PPE appropriate to the agent, and a validated decontamination procedure for the sort chamber and fluidics between samples and at the end of the run. Confirm the specific containment requirement with the biosafety officer and the sort operator before scheduling time — requirements vary by agent, by instrument (some sorters are certified for enclosed BSL-2 use, others are not), and by institution, and this is not a determination to make unilaterally as the requesting investigator.

MIFlowCyt-Compliant Reporting and Data Deposition (FlowRepository)

Flow cytometry has its own minimum-reporting standard for exactly the reason this guide opened with: a dot plot or a summary percentage is uninterpretable, and unreproducible, without the experimental and instrument context behind it. The Minimum Information about a Flow Cytometry Experiment (MIFlowCyt) standard, developed and maintained by the International Society for Advancement of Cytometry (ISAC), specifies the minimum information a publication or dataset needs to report for another lab to independently interpret and evaluate the result — the experiment overview, specimen description, reagents (exact fluorophore conjugates and clones), instrument configuration (lasers, filters, detector assignments), and the data-transformation/gating logic used to analyze the raw data. A number of journals, including Cytometry Part A (ISAC’s own journal), require or strongly encourage MIFlowCyt-compliant reporting for flow data submitted alongside a manuscript.

Raw flow data is exchanged as .fcs files, in the ISAC-maintained Flow Cytometry Standard file format (current version FCS 3.1) — a binary list-mode format that stores the full per-cell, per-parameter measurement table described earlier in this guide, not just summary statistics. FlowRepository is the community data repository built around this standard: it requires MIFlowCyt-compliant metadata annotation for a deposited dataset and is the deposition target most often specified by funder data-sharing requirements and journal data-availability policies for flow data, filling a comparable role to GEO or SRA for sequencing data. Depositing raw .fcs files and complete metadata — not just a figure of the final gated plot — is what makes a flow result reusable and independently checkable rather than merely reported.

Core-Facility Access, Recharge Rates, and Budgeting Instrument Time on a Grant

Almost no individual lab owns and maintains its own cytometer or sorter — the instrumentation, laser configurations, and, for sorting, trained operator time are expensive enough that most institutions provide access through a shared core research facility rather than per-lab purchase. That has direct budgeting and compliance consequences a purely technical treatment of the method skips over.

Recharge Rates and Federal Cost Principles

Core facilities that serve federally funded research recover their operating costs through per-use recharge (chargeback) rates rather than through indirect (F&A) cost recovery, governed for federally funded institutions by 2 CFR 200.468, “Specialized service facilities”. The core requirement: rates must be based on actual usage, must not discriminate between federally funded and other users (including the institution’s own internal use), and must be designed to recover only the aggregate cost of providing the service, not to generate a surplus, with rates reviewed and adjusted at least biennially against actual over/under-recovery. In practice, analyst time, sorter time, and reagent costs are typically billed at different published rates; sorting is usually priced higher than unassisted analysis because it requires a trained operator for the full run; and internal (institutional) users are billed at a different, typically lower, rate than external users, specifically because the internal rate is the one federal cost-principle compliance is checked against.

Budgeting Instrument Time on a Grant

Because recharge rates are usage-based, instrument time is a real, budgetable line item, not a sunk cost, and it needs a realistic estimate at the proposal stage: number of samples, panel complexity (a longer, more complex panel takes proportionally longer to acquire per sample and often needs more setup/compensation or unmixing time), whether cell sorting — which requires booked operator time, not just machine time — is needed versus analysis alone, and whether a pilot experiment to validate a new panel is budgeted separately from the production runs that follow it. Most core facilities publish current rate schedules and require advance scheduling, and many require or strongly recommend a panel-design consultation before a new multicolor panel is run for the first time; building that consultation into the project timeline avoids discovering a panel-design problem (see above) only after committing instrument time and reagents to a full experiment.

Data-Management Obligations for Large FCS Datasets

A single multi-parameter sort or a longitudinal analysis study can generate a large volume of raw .fcs files plus derived analysis files (gating hierarchies, compensation/unmixing matrices, exported statistics) that need the same treatment as any other research dataset under a funder’s data management plan: a defined storage location and retention period, a plan for who can access raw versus processed data, and, where a funder or journal requires it, a public deposition path (FlowRepository, per above) before or at publication. Core facilities often provide short-term data storage and analysis-workstation access as part of the recharge rate, but long-term retention and public deposition are usually the investigator’s responsibility, not the facility’s, and are worth confirming explicitly rather than assuming.

Frequently Asked Questions

What is the difference between an FMO control and an isotype control?

An FMO control (the full panel minus one fluorophore) measures spillover from the rest of the panel into that channel and is the standard way to set an accurate gate boundary. An isotype control (a non-specific antibody of matching isotype and conjugate) estimates non-specific antibody binding, not spillover. They answer different questions and aren’t substitutes for each other — see the controls section above.

What do FSC and SSC stand for, and what do they measure?

Forward scatter (FSC) and side scatter (SSC). FSC correlates with a cell’s relative size; SSC correlates with its internal granularity and complexity. Together they’re typically the first plot in a gating strategy, used to separate intact cells from debris and to distinguish broad cell types by size and granularity alone.

Why do I need to gate on singlets before anything else?

Two or more cells passing through the laser stuck together register as one event with an inflated pulse area or width relative to its height. Left ungated, these doublets can appear as false double-positive populations in downstream marker gates. Comparing pulse height to pulse area or width on a scatter channel isolates true single-cell events before any marker is analyzed.

What’s the difference between a dot plot and a histogram?

A histogram shows the distribution of one parameter (event count vs. signal intensity), which is ideal for comparing a single marker’s distribution across samples or against a control. A dot plot shows two parameters against each other, one dot per cell, which is ideal for identifying populations defined by two markers at once. Both are drawn from the same underlying per-cell data.

Why does my dot plot show a diagonal smear between two populations that should be separate?

This is the classic visual signature of a compensation problem — either under- or over-compensated spillover between two fluorophores whose emission spectra overlap. Check the single-stain compensation controls for the fluorophores involved before concluding the smear reflects a real biological intermediate population.

What’s the real difference between compensation and spectral unmixing?

Both correct for the same underlying problem — fluorophore emission spectra overlapping — but conventional compensation subtracts a calculated spillover value between single peak-emission channels, while spectral unmixing uses each dye’s complete emission spectrum, captured across many detectors, to mathematically separate dyes that a peak-channel approach can’t distinguish. Reference controls and design tools for one platform don’t transfer to the other; see the section above.

How do I decide which fluorophore goes with which antibody in a panel?

Rank antigens by expression density and biological priority, rank fluorophores by staining index (brightness relative to background spread), and assign the brightest fluorophores to the dimmest or most important antigens first. Then check the pairings against a spillover spreading matrix before finalizing — see the Panel Design section above for the full sequence.

What is spillover spreading, and why doesn’t compensation fix it?

Compensation corrects the mean shift spillover causes in a channel, but it doesn’t remove the extra variance (spread) that spillover adds to that channel. A spillover spreading matrix quantifies that added spread for every fluorophore pair in a panel, and is used to catch a bright-fluorophore/dim-target pairing that will stay noisy even after correct compensation.

Do I need special biosafety precautions to sort BSL-2 material?

Yes — sorting generates aerosols at the point the stream breaks into droplets, a materially different exposure risk than closed-system analysis. Institutional biosafety committees typically require an aerosol management enclosure, a documented risk assessment and IBC approval, appropriate PPE, and a validated decontamination procedure before BSL-2-or-higher material is sorted; confirm requirements with your biosafety officer before scheduling instrument time.

What is MIFlowCyt and do I need to follow it?

MIFlowCyt (Minimum Information about a Flow Cytometry Experiment) is ISAC’s minimum-reporting standard for flow data, covering specimen, reagent, instrument, and analysis details needed for another lab to interpret and reproduce a result. It’s increasingly required or encouraged by journals (including Cytometry Part A) and is the metadata standard FlowRepository requires for public dataset deposition.

Why does my institution charge different rates for sorting versus analysis?

Sorting requires a trained operator running the instrument for the full session, while unassisted analysis on a walk-up analyzer typically doesn’t; core facility recharge rates under federal cost-principle rules (2 CFR 200.468) must reflect actual usage-based costs, which is why sorter time, analyst-assisted time, and self-service analysis time are usually billed at different published rates.

Flow cytometry data is downstream of two other common lab techniques worth understanding alongside it: cells are typically prepared from a live culture (see the cell culture basics guide), and antibody-based detection principles — specificity, titration, and validation — carry over directly from methods like western blotting and ELISA, which use many of the same antibodies against the same targets in a different readout format. For the administrative side of running flow experiments through shared instrumentation, see Core Facility (Research Core): Funding & Rates and core facility management software; for biosafety enclosures used in sample prep and sorting, see how to properly use a biosafety cabinet and Class I vs. II vs. III biosafety cabinets. For broader lab operations and equipment context, see the Laboratory Operations hub.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →

Regulatory Radar

Stop finding out after the fact

$29/month, cancel anytime. Daily digest updates from our analysis, a dashboard holding the same items, and a cited assistant for everything they raise.

  • Federal Register, Federal Register+, Grants.gov, Regulations.gov, NSF News, UKRI, plus CASRAI’s own published content.
  • 44,322 indexed passages, and every answer cites the ones it drew on.